Join the Prostate Cancer group to help and get support from people like you.
Prostate Cancer News
Related terms: Cancer, Prostate, Carcinoma of Prostate
MicroRNA-Based Germline Signature Predicts RT-Induced Genitourinary Toxicity in Prostate Cancer
FRIDAY, April 18, 2025 – A biomarker consisting primarily of microRNA-based germline biomarkers (mirSNPs), PROSTOX, is valid for predicting radiotherapy (RT)-induced genitourinary (GU) toxicity in...
Gene Test Predicts Urinary Problems From Prostate Cancer Radiation Therapy
WEDNESDAY, April 16, 2025 – Radiation therapy is commonly used to treat prostate cancer, but it can cause embarrassing urinary problems in some men. But a new genetic test appears capable of sussing...
Prostate Cancer Screening Program Beneficial in Top Decile of Polygenic Risk Score
MONDAY, April 14, 2025 – A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score identifies clinically significant disease, according...
NeuroSAFE Improves Erectile Function After Radical Prostatectomy
THURSDAY, April 3, 2025 – Use of the NeuroSAFE technique, a standardized frozen section analysis that enables accurate real-time detection of positive surgical margins during nerve sparing in...
Similar Efficacy Seen for Isodose, Dose-Escalated MHFRT, CFRT in Prostate Cancer
TUESDAY, April 1, 2025 – For patients with prostate cancer, isodose and dose-escalated moderately hypofractionated radiotherapy (MHFRT) have similar efficacy as conventionally fractionated...
FDA Approves Novartis Radioligand Therapy Pluvicto for Earlier Use Before Chemotherapy in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
Basel, March 28, 2025 – Novartis announced today that the US Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for patients with prostate-specific membrane a...
New Surgical Technique Preserves Erectile Function In Prostate Cancer Patients
FRIDAY, March 28, 2025 – A pioneering technique can help nearly twice as many men preserve erectile function following prostate cancer surgery, researchers say. The new surgical method, called...
Longer PSA Monitoring in Patients With Persistent PSA May Reduce Overtreatment
THURSDAY, March 27, 2025 – Assessment of prostate-specific antigen (PSA) level for three months after radical prostatectomy (RP) for prostate cancer may minimize overtreatment, according to a study...
FDA Approves Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection) for Prostate Cancer Imaging
Melbourne Australia | 21 March 2025 – Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Gozellix® (TLX007-CDx, ...
Black Cancer Death Rate Declining, But Higher Risk Remains
FRIDAY, Feb. 21, 2025 – Cancer deaths among Black men and women in the U.S. have declined during the past decade in the United States, a new American Cancer Society (ACS) report says. The cancer...
Talazoparib + Enzalutamide Tied to Improved Overall Survival in Metastatic Prostate Cancer
WEDNESDAY, Feb. 19, 2025 – For patients with metastatic castration-resistant prostate cancer (mCRPC) unselected for homologous recombination repair (HRR) gene alterations, talazoparib (TALA) +...
Prostate Cancer Screening Hits the Streets With the 'Man Van'
TUESDAY, Feb. 18, 2025 -- A mobile "Man Van" screening program detected dozens of prostate cancer cases in disadvantaged neighborhoods of London, researchers report. A team led by Dr. Masood Moghul ...
Exercise Regimen Can Improve Fatigue in Patients With Advanced Prostate Cancer
TUESDAY, Feb. 18, 2025 – For patients with advanced prostate cancer (aPC), completion of a 12-week supervised exercise regimen leads to a significant improvement in fatigue and peak exercise...
Testosterone Recovery Linked to Overall Survival in High-Risk Prostate Cancer
TUESDAY, Feb. 18, 2025 – Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients with high-risk prostate cancer receiving...
Mobile Prostate Cancer Screening Clinic Can ID the Disease in Disadvantaged Men
TUESDAY, Feb. 18, 2025 – A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a study presented at the American Society of Clinical...
Further information
Related condition support groups
Related drug support groups
Lupron, estradiol, Lupron Depot, Premarin, Estrace, Xtandi, Zytiga